Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leiomyoma 2Hemorrhage 2Sexual Infantilism 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Myoma 1Myofibroma 1Diabetes Insipidus 1Craniopharyngioma 1Blood Loss, Surgical 1Adenomyosis 1

Interventions

Surgical Procedures, Operative 4Magnetic Resonance Spectroscopy 3Exenatide 3tocilizumab 2Temozolomide 2Surveys and Questionnaires 2Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2Donepezil 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1tozuleristide 1tovorafenib 1temsirolimus 1gallium Ga 68 dotatate 1entinostat 1dabrafenib 1cobimetinib 1carboxyamido-triazole 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1anlotinib 1Verteporfin 1Vemurafenib 1Tumor Burden 1Transurethral Resection of Bladder 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Craniopharyngioma × Oxytocin × Clear all
NCT02849743 2022-10-05

Intranasal Oxytocin in Hypothalamic Obesity

Children's Hospital of Philadelphia

Phase 2 Completed
18 enrolled 18 charts
CNS

Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡